|
2025
|
P/S
|
Pharmaceutical products for the treatment of a genetic
disease. |
|
|
P/S
|
Pharmaceutical products for the treatment of a genetic disease. |
|
|
P/S
|
Pharmaceutical semi- finished products for the treatment of genetic diseases, cancer or infectiou... |
|
2024
|
Invention
|
Treatment regimens for therapeutic effector components that act via an intracellular molecular ta... |
|
|
Invention
|
Conjugates of saponin and antisense oligonucleotides for use in the treatment of neurodegenerativ... |
|
|
Invention
|
Pharmaceutical compositions for treatment of central nervous system disorders. The present invent... |
|
|
Invention
|
Improved treatment regimens for therapeutic effector components that act via an intracellular mol... |
|
2023
|
Invention
|
Compositions of polyplexes and saponins. The invention lies in the field of delivery of nucleic a... |
|
2022
|
Invention
|
Compositions comprising therapeutic nucleic acid and saponin for the treatment of muscle-wasting ... |
|
|
Invention
|
Compositions comprising therapeutic nucleic acid and targeted saponin for the treatment of muscle... |
|
|
Invention
|
Targeted saponin-nucleic acid conjugates for treatment of muscle wasting disorders.
The inventio... |
|
|
Invention
|
Targeted saponin-nucleic acid conjugates for treatment of muscle wasting disorders. The invention... |
|
|
Invention
|
Cytosolic delivery of genome editing tools.
A first aspect of the invention relates to the use o... |
|
|
Invention
|
Cytosolic delivery of genome editing tools. in vitroe.gin vitroe.g.in vitroin vitroin vitro deliv... |
|
|
Invention
|
Semicarbazone-based saponin conjugate. The invention relates to a saponin derivative based on a s... |
|
|
Invention
|
Conjugate of saponin, oligonucleotide and galnac. The invention relates to a conjugate comprising... |
|
|
Invention
|
Semicarbazone-based saponin conjugate.
The invention relates to a saponin conjugate comprising a... |
|
|
Invention
|
Semicarbazone-based saponin conjugate. in vitro ex vivo ex vivo method for transferring a molecul... |
|
2021
|
Invention
|
Conjugate of saponin, oligonucleotide and galnac.
The invention relates to a conjugate comprisin... |
|
|
Invention
|
Semicarbazone-based saponin conjugate.
The invention relates to a saponin derivative based on a ... |
|
|
Invention
|
Conjugate of saponin, oligonucleotide and galnac. in vitroex vivoex vivo method for transferring ... |
|
|
Invention
|
Saponin derivatives for use in medicine.
The invention relates to a Quillaja saponaria saponin d... |
|
|
Invention
|
Therapeutic combination of galnac-oligonucleotide conjugate and saponin, and uses thereof.
The i... |
|
|
Invention
|
Saponin derivatives for use in medicine.
The invention relates to a saponin derivative based on ... |
|
|
Invention
|
Saponin derivatives for use in medicine. The invention relates to a saponin derivative based on a... |
|
|
Invention
|
Hydrazone-based saponin derivatives.
The invention relates to a saponin derivative The invention... |
|
|
Invention
|
Conjugate of a single domain antibody, a saponin and an effector molecule, pharmaceutical composi... |
|
|
Invention
|
Conjugate of saponin and single-domain antibody, pharmaceutical composition comprising said conju... |
|
|
Invention
|
Combination of an antibody-drug conjugate and an antibody-saponin conjugate.
The invention relat... |
|
|
Invention
|
Conjugate of galnac and saponin, therapeutic composition comprising said conjugate and a galnac-o... |
|
2020
|
Invention
|
Bioactive saponin linked to a functional moiety.
The invention relates to an endosomal and/or ly... |
|
|
Invention
|
Saponin derivatives with improved therapeutic window.
The invention relates to a saponin derivat... |
|
|
Invention
|
Combination comprising an adc or an aoc comprising a vhh, and a saponin or a ligand-saponin conju... |
|
2019
|
Invention
|
Improved cell-targeting binding molecule.
The invention relates to a therapeutic combination, co... |
|
|
Invention
|
Saponin conjugates.
The invention relates to a therapeutic combination for use as a medicament, ... |
|
|
Invention
|
Improved antibody-oligonucleotide conjugate.
The invention relates to a ligand-effector moiety p... |
|
|
Invention
|
Drug conjugate.
The invention relates to antibody-drug conjugates (ADC) that are potentiated by ... |
|
|
Invention
|
Antibody-drug conjugate with improved therapeutic window.
The invention relates to a therapeutic... |
|
|
Invention
|
Biologically active cluster of molecules.
The invention relates to a molecular scaffold suitable... |
|
|
Invention
|
Saponin conjugated to epitope-binding proteins.
The invention relates to a therapeutic combinati... |
|
|
Invention
|
Saponin conjugates.
The current invention relates to an effector moiety capable of inducing an i... |
|
2017
|
P/S
|
Pharmaceutical semi-finished products. Medicine; Crude drugs. |
